In a recent research, scientists from the University of Leeds and US colleagues at the Mayo Clinic in Minnesota have discovered a new vaccine against prostate cancer, which they have described as "shotgun". Scientists have revealed that the vaccine works mainly on the immune system to search and destroy prostate tumors. The vaccine has no impact on healthy tissues. The research was published recently in the journal Nature Medicine.

Professor Alan Melcher, from the University of Leeds, said that the "shotgun" works by exploding the immune system with thousands of pieces of prostate protein DNA, with some of these recognized by the body as targets. After the immune system has been stimulated with this information, it looks for the same proteins in the body and as found in tumor cells.

Researchers have revealed that the clinical trials of the vaccine could start within two years. The researchers have carried out the laboratory tests of the vaccine on mice suffering from prostate cancer. The findings revealed that the vaccine had no side effects on the mice.

Researchers have said that further research is required to be carried out in this field to develop a potential treatment for prostate cancer.